Litigation Details for VIVUS, INC. v. HETERO USA, INC. (D.N.J. 2016)
✉ Email this page to a colleague
VIVUS, INC. v. HETERO USA, INC. (D.N.J. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-07-27 |
Court | District Court, D. New Jersey | Date Terminated | 2017-01-08 |
Cause | 28:1338 Patent Infringement | Assigned To | Katharine Sweeney Hayden |
Jury Demand | None | Referred To | Cathy L. Waldor |
Parties | HETERO USA, INC. | ||
Patents | 6,656,935; 7,501,409 | ||
Attorneys | CHARLES MICHAEL LIZZA | ||
Firms | Christina Lynn Saveriano | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in VIVUS, INC. v. HETERO USA, INC.
Details for VIVUS, INC. v. HETERO USA, INC. (D.N.J. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-07-27 | 1 | United States Patent Nos. 6,656,935 (“the ’935 patent”) and 7,501,409 (“the ’409 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patents-In-Suit 17. On Dec. 2, 2003, the United States Patent and Trademark …the exclusive licensee of the ’935 patent. A copy of the ‘935 patent is attached hereto as Exhibit A. …the exclusive licensee of the ’409 patent. A copy of the ’409 patent is attached hereto as Exhibit B. | External link to document | |
2017-01-04 | 20 | Filed 01/05/17 Page 4 of 5 Page|D: 196 Patent Nos. 6,656,935 and 7,501,409 and/or whether the product…claims of United States Patent Nos. 9,656,935 and 7,501,409 (“the Asserted Patents”) in connection with … the expiration of the Asserted Patents was a technical act of patent infringement with respect to one…Court has subject matter jurisdiction over this patent infringement action (the “Action”). The Court has… and Drug Administration (“FDA”). Asserted Patents are valid and enforceable in this Action. 4. For | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |